Table 3. Averted CHD and CVD Events Per 1,000 Persons, Base-Case MESA Event Rates.

	ATP III (Events)	Treat All (Δ Events, Compared to ATP III)	CAC* (Δ Events, Compared to ATP III)
5 Years
CHD Events	31.7	27.9 Δ = −3.9)	26.7 Δ = −5.1)
CVD Events	40.8	35.7 Δ = −5.1)	35.0 Δ = −5.8)
10 Years
CHD Events	52.3	46.1 Δ = −6.2)	44.5 Δ = −7.9)
CVD Events	72.7	64.0 Δ = −8.6)	62.9 Δ = −9.8)

Note: Simulated events per 1,000 persons, by risk assessment and treatment strategy. The results displayed in this table value outcomes in terms of averted events, but not QALYs. Results reflect all base-case model assumptions and 1x MESA event rates.

* Column displays results for the scenario where patients with CAC≥1 are advised to initiate statins (intensive therapy for CAC≥100, and standard therapy for 1≤CAC<100).